Trial reportThe Journal of urology2012
Treatment success of retropubic and transobturator mid urethral slings at 24 months.
Trial report in The Journal of urology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 86 citations in OpenAlex.
- Defining success after surgical treatment of stress urinary incontinence.American journal of obstetrics and gynecology · 2024Trial
- Two-Year Results of Burch Compared With Midurethral Sling With Sacrocolpopexy: A Randomized Controlled Trial.Obstetrics and gynecology · 2018Trial
- Prospective and randomized clinical trial comparing transobturator versus retropubic sling in terms of efficacy and safety.International urogynecology journal · 2018Trial
- Long-term efficacy of the trans-obturator and retropubic mid-urethral slings for stress urinary incontinence: update from a randomized clinical trial.World journal of urology · 2016Trial
- Retropubic tension-free vaginal tape and inside-out transobturator tape: a long-term randomized trial.International urogynecology journal · 2016Trial
- Change in Overactive Bladder Symptoms After Surgery for Stress Urinary Incontinence in Women.Obstetrics and gynecology · 2015Trial
- Stress Urinary Incontinence Procedure Outcomes in the < 40-Year-Old Population: A Multicenter Study.International urogynecology journal · 2026Article
- Prediction of success of slings in female stress incontinence, statistical and AI modeling.Scientific reports · 2025Article
- Postoperative Complications in Women Submitted to a Transobturator Tape Sling: An 11-Year Retrospective Cohort.Cureus · 2025Article
- Evolution of stress urinary incontinence (SUI) outcomes assessment: a narrative review.Gynecology and pelvic medicine · 2024Review
- Retropubic tape surgery for stress urinary incontinence: can women be cured without voiding dysfunction?World journal of urology · 2023Article
- Twenty-Five Years of the Midurethral Sling: Lessons Learned.International neurourology journal · 2022Article
- Complications and their treatment after midurethral tape implantation using retropubic and transobturator approaches for treatment of female stress urinary incontinence.Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2018Article
- Safety considerations for synthetic sling surgery.Nature reviews. Urology · 2015Review
- Histopathology of excised midurethral sling mesh.International urogynecology journal · 2015Article
- 5-year longitudinal followup after retropubic and transobturator mid urethral slings.The Journal of urology · 2015Observational
- Pelvic organ prolapse in a cohort of women treated for stress urinary incontinence.American journal of obstetrics and gynecology · 2014Observational
- Management of failed stress urinary incontinence surgery.Current urology reports · 2014Review
- Urgency after a sling: review of the management.Current urology reports · 2014Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 12 institutions in 1 country.
Funding
Abstract
purposeLonger term comparative efficacy information regarding transobturator and retropubic mid urethral slings is needed. We report 24-month continence rates, complications and symptom outcomes from a randomized equivalence trial. MATERIALS AND
methodsPrimary outcomes were objective (negative stress test, negative pad test and no re-treatment for stress urinary incontinence) and subjective (no self-report of stress urinary incontinence symptoms, no leakage episodes on 3-day bladder diary and no re-treatment for stress urinary incontinence) success at 24 months. The predetermined equivalence margin was ± 12%.
resultsOf 597 randomized participants 516 (86.4%) were assessed. Objective success rates for retropubic and transobturator mid urethral slings were 77.3% and 72.3%, respectively (95% CI for difference of 5.1% was -2.0, 12.1), and subjective success rates were 55.7% and 48.3%, respectively (CI for difference of 7.4% was -0.7, 15.5). Neither objective nor subjective success rates met the prespecified criteria for equivalence. Patient satisfaction (retropubic 86.3% vs transobturator 88.1%, p = 0.58), frequency of de novo urgency incontinence (retropubic 0% vs transobturator 0.3%, p = 0.99) and occurrence of mesh exposure (retropubic 4.4% vs transobturator 2.7%, p = 0.26) were not significantly different. The retropubic mid urethral sling group had higher rates of voiding dysfunction requiring surgery (3.0% vs 0%, p = 0.002) and urinary tract infections (17.1% vs 10.7%, p = 0.025), whereas the transobturator group had more neurological symptoms (9.7% vs 5.4%, p = 0.045).
conclusionsObjective success rates met the criteria for equivalence at 12 months but no longer met these criteria at 24 months. Subjective success rates remained inconclusive for equivalence. Patient satisfaction remained high and symptom severity remained markedly improved. Continued surveillance is important in women undergoing mid urethral sling surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.